Searchable abstracts of presentations at key conferences in endocrinology

ea0099p503 | Endocrine-Related Cancer | ECE2024

Presurgical lactate dehydrogenase (LDH) levels: A risk factor for disease progression in operated adrenocortical carcinomas

Carreira Ana , Guiomar Joana , Festas Diana , Catarino Diana , Rodrigues Dircea , Moreno Carolina , Melo Miguel , Paiva Isabel

Introduction: Adrenocortical carcinoma (ACC) is a rare malignancy with high recurrence and poor prognosis. Lactate dehydrogenase (LDH) is an enzyme of the glycolytic pathway that is associated with tumour progression in several cancers. To date, evidence on the prognostic value of LDH in ACC is limited.Aims: To assess the impact of LDH in disease-free survival (DFS) in operated ACC.Materials and methods: Retrospective cohort study ...

ea0099ep23 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

3-year setmelanotide weight outcomes in patients with bardet-biedl syndrome and obesity

Yanovski Jack , Angel Martos-Moreno Gabriel , Malhotra Sonali , Yuan Guojun , Chung Wendy , Dollfus Helene , Clement Karine

Background: Bardet-Biedl Syndrome (BBS) is a rare genetic disease in which impaired melanocortin-4 receptor (MC4R) signaling leads to hyperphagia and obesity. In an index Phase 3 trial, broad clinical benefit was observed in patients with BBS based on improvement or stabilization in ≥1 measure of weight, hunger, or quality of life with 1 year of treatment with the MC4R agonist setmelanotide. Reported here are long-term extension (LTE) weight outcomes after 3 years of set...

ea0099ep584 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

A novel lipoprotein lipase mutation in familial chylomicronemia syndrome – two case reports

Moreno Telma , Ribeiro Sara , Freixo Joao , Pinhao Silvia , Correia Flora , Rodrigues Elisabete

Introduction: Familial chylomicronemia syndrome (FCS) is a rare inherited disorder of lipoprotein metabolism leading to severe hypertriglyceridemia and increased risk for acute pancreatitis. Mutations in the lipoprotein lipase (LPL) gene account for the majority of cases of monogenic chylomicronemia.Methods: We report the cases of two white males with a novel homozygous mutation in position 332 of the LPL gene.Res...

ea0099ep762 | Thyroid | ECE2024

Treatment of pediatric grave’s disease: a single-center experience

Moreno Telma , Filipe Ribeiro Joana , Ferreira Sofia , Costa Carla , Santos Silva Rita , Castro-Correia Cintia

Introduction: Grave’s disease is a rare disease in children. Treatment options are the same as in adults but remission rate with antithyroid drugs (ATD) appears to be lower in children and more prolonged courses of ATD are recommended. We aimed to evaluate the outcome of ATD treatment and to identify factors associated with remission.Methods: Retrospective study of 36 pediatric patients diagnosed with Grave’s disease at the Pediatric Department...

ea0090p385 | Endocrine-related Cancer | ECE2023

Characterization of telomerase/shelterin system in endocrine intracranial tumors at clinical, transcriptomic, and functional levels

G-Garcia Miguel E. , Flores-Martinez Alvaro , De la Rosa-Herencia Ana S. , Cano Gonzales David , Cardenas Eugenio , Solivera Juan , Gahete Manuel D. , Soto-Moreno Alfonso , Angeles Galvez-Moreno Maria , Fuentes-Fayos Antonio C. , M Luque Raul

Intracranial tumors (IT) comprise a heterogenous group of neoplasias (e.g., pituitary/brain tumors and craniopharyngiomas), characterized by difficult diagnosis based on MRI, challenging prognostic predictors and lack of effective therapeutic strategies. In addition, these tumors are usually associated with neurological disorders and severe comorbidities (e.g., those associated with Cushing syndrome, Acromegaly, etc.), worsening the quality life of patients. In this context, s...

ea0090p542 | Late-Breaking | ECE2023

Characterization of RNA expression and clinical outcomes in patients with aggresive pituitary tumors treated with temozolomide

Venegas Moreno Eva , Remon Pablo , Dios-Fuentes Elena , Pinar Gutierrez Ana , Manuel Canelo Juan , Oliva Rosario , Alonso-Garcia Miriam , Cardenas Eugenio , Kaen Ariel , G-Garcia Miguel E. , Cano Gonzales David , Luque Raul M. , Soto-Moreno Alfonso

Methods: Descriptive retrospective study of the clinical outcomes and RNA expression in aggressive pituitary tumors treated with temozolomide. RNA expression was studied in tumor samples normalized to housekeeping genes including GH, POMC, PRL, αsub, FSH, LH, TSH, sst1, sst2, sst3, sst5, sst5b, sst5c, DR1, DR2T, DR2L, DR4, DR5, Ghrelin, In1-Ghrelin, GOAT, GHRR1b, AVPR1b, GHRH-R, GnRH-R, Ki-67, PTTG1, CRHR1.Results: Ten patients were treated. 30% (3)...

ea0049ep178 | Endocrine tumours and neoplasia | ECE2017

Dysregulation of the components of the splicing machinery in neuroendocrine tumors and its association with malignancy and aggressiveness

Pedraza-Arevalo Sergio , Alors-Perez Emilia , Herrera-Martinez Aura D. , del Rio-Moreno Mercedes , Sanchez-Sanchez Rafael , Ortega-Salas Rosa , Serrano-Blanch Raquel , Galvez-Moreno Maria A. , Gahete Manuel D. , Luque Raul M. , Castano Justo P.

Dysregulation of the splicing machinery is emerging as a novel cancer hallmark due to its association with multiple dysfunctions in tumor cells. An inappropriate function of the components of this machinery (spliceosome) could be primarily linked with the generation of tumor-associated aberrant splicing variants. In line with this, we have previously reported that overexpression of aberrantly spliced variants of somatostatin receptor 5 (sst5TMD4) and ghrelin (In1-ghrelin) is d...

ea0049ep790 | Endocrine tumours and neoplasia | ECE2017

Altered expression of the components of the splicing machinery is associated to increased malignancy and expression of aberrant splicing variants in prostate cancer

Jimenez-Vacas Juan M , Gahete Manuel D , Pedraza-Arevalo Sergio , del Rio-Moreno Mercedes , Hormaechea-Agulla Daniel , Gomez-Gomez Enrique , Carrasco-Valiente Julia , del Mar Moreno Maria , Jose Requena-Tapia Maria , Castano Justo P , Luque Raul M

: Prostate cancer (PCa) is the most common cancer among men in developed countries. Unfortunately, the heterogeneity of this malignancy hinders the finding of new biomarkers and therapeutic tools. A potential factor contributing to PCa is alternative splicing, which can generate the appearance of oncogenic variants involved in PCa aggressiveness. Thus, we hypothesized that the alteration of the splicing machinery (spliceosome components and splicing factors (SFs)) could be ass...

ea0044p157 | Neuroendocrinology and pituitary | SFEBES2016

Use of biguanides in the treatment of pituitary adenomas, an in vitro approach

Ibanez-Costa Alejandro , Carmen Vazquez-Borrego Ma , Fuentes-Fayos Antonio C. , Venegas-Moreno Eva , Galvez Ma Angeles , Soto-Moreno Alfonso , Kineman Rhonda D. , Castano Justo P. , Luque Raul M.

Pituitary adenomas (PA) comprise a commonly underestimated pathology in terms of incidence and associated morbi-mortality. Although somatostatin analogs and dopamine antagonists constitute the main medical treatments for PAs, an appreciable subset of patients are resistant or poorly responsive to these drugs and hence is crucial the search for new therapies. Biguanides such as metformin (MF; commonly used to treat type-2 diabetes), phenformin (PF) and buformin (BF) have been s...

ea0041ep398 | Developmental endocrinology | ECE2016

Evaluation of the series of adults with inborn metabolic diseases followed in endocrinology in Andalusia (Spain)

Marin Montserrat Gonzalo , Molero Inmaculada Gonzalez , Moreno Eva Venegas , Fuentes Elena Dios , Alonso Javier Blasco , Delgado Maria Bueno , Nieto Juliana Serrano , Salinas Carlos Sierra , Fuster Gabriel Olveira , Madueno Francisco Tinahones , Moreno Alfonso Soto

Objectives: The transition from the paediatric age to the adult is a particularly vulnerable period in patients with metabolic congenital diseases (mcd). In andalusia two adults’ units exist (seville and malaga) for the follow-up of these patients. Our aim in this study was to evaluate the current series of attended patients.Material and methods: We evaluated all patients transferred to the adult units since 2008. The clinical records were analyzed ...